###begin article-title 0
###xml 31 36 <span type="species:ncbi:10090">Mouse</span>
Transgenic CHD1L Expression in Mouse Induces Spontaneous Tumors
###end article-title 0
###begin p 1
Conceived and designed the experiments: MC JdH LH BjZ LC SLT XyG. Performed the experiments: MC LH LC SLT. Analyzed the data: MC JdH LH BjZ LC SLT XyG. Contributed reagents/materials/analysis tools: XyG. Wrote the paper: MC.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 292 297 292 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 357 362 357 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 448 453 448 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 482 487 482 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
Amplification of 1q21 is the most frequent genetic alteration in hepatocellular carcinoma (HCC), which was detected in 58-78% of primary HCC cases by comparative genomic hybridization (CGH). Using chromosome microdissection/hybrid selection approach we recently isolated a candidate oncogene CHD1L from 1q21 region. Our previous study has demonstrated that CHD1L had strong oncogenic ability, which could be effectively suppressed by siRNA against CHD1L. The molecular mechanism of CHD1L in tumorigenesis has been associated with its role in promoting cell proliferation.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 27 34 27 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 53 58 53 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 60 65 60 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 446 451 446 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 497 502 497 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 556 561 556 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 684 689 684 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 847 851 847 851 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 99 104 <span type="species:ncbi:10090">mouse</span>
###xml 183 198 <span type="species:ncbi:10090">transgenic mice</span>
###xml 452 467 <span type="species:ncbi:10090">transgenic mice</span>
###xml 586 591 <span type="species:ncbi:10090">mouse</span>
To further investigate the in vivo oncogenic role of CHD1L, CHD1L ubiquitous-expression transgenic mouse model was generated. Spontaneous tumor formations were found in 10/41 (24.4%) transgenic mice, including 4 HCCs, but not in their 39 wild-type littermates. In addition, alcohol intoxication was used to induce hepatocyte pathological lesions and results found that overexpression of CHD1L in hepatocytes could promote tumor susceptibility in CHD1L-transgenic mice. To address the mechanism of CHD1L in promoting cell proliferation, DNA content between CHD1L-transgenic and wildtype mouse embryo fibroblasts (MEFs) was compared by flow cytometry. Flow cytometry results found that CHD1L could facilitate DNA synthesis and G1/S transition through the up-regulation of Cyclin A, Cyclin D1, Cyclin E, CDK2, and CDK4, and down-regulation of Rb, p27Kip1, and p53.
###end p 5
###begin title 6
Conclusion/Significance
###end title 6
###begin p 7
###xml 47 52 47 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
Taken together, our data strongly support that CHD1L is a novel oncogene and plays an important role in HCC pathogenesis
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 126 129 126 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006727-Llovet1">[1]</xref>
###xml 256 259 256 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006727-ElSerag1">[2]</xref>
###xml 524 527 524 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006727-Montalto1">[3]</xref>
###xml 730 733 730 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006727-Marchio1">[4]</xref>
###xml 734 737 734 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006727-Guan1">[7]</xref>
###xml 803 806 803 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006727-Guan1">[7]</xref>
###xml 808 811 808 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006727-Qin1">[8]</xref>
###xml 306 323 <span type="species:ncbi:10407">hepatitis B virus</span>
###xml 328 345 <span type="species:ncbi:11103">hepatitis C virus</span>
###xml 684 692 <span type="species:ncbi:9606">patients</span>
Hepatocellular carcinoma (HCC) is one of the most common solid tumors in the world affecting one million individuals annually [1]. The prognosis of HCC is very poor and the overall 5-year survival rate is less than 5%, mainly because of the late diagnosis [2]. Although different etiologic factors such as hepatitis B virus and hepatitis C virus infection, aflatoxin exposure, and alcoholic cirrhosis have been associated with the development of HCC, the genetic events involved in the pathogenesis of HCC are still unclear [3]. One of the most frequently detected genetic alterations in HCC is the amplification of the long arm of chromosome 1, which has been detected in 58-78% HCC patients by comparative genomic hybridization [4]-[7]. A minimal amplified region at 1q has been narrowed down to 1q21 [7], [8], suggesting the existence of an oncogene at 1q21 which plays an important role in HCC pathogenesis.
###end p 9
###begin p 10
###xml 216 221 216 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 235 239 235 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALC1</italic>
###xml 255 258 255 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006727-Ma1">[9]</xref>
###xml 260 265 260 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 433 438 433 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 610 613 610 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006727-Ma1">[9]</xref>
###xml 642 649 642 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 668 673 668 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 675 680 675 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 953 958 953 958 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 1003 1008 1003 1008 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 563 572 <span type="species:ncbi:10090">nude mice</span>
###xml 714 719 <span type="species:ncbi:10090">mouse</span>
###xml 809 824 <span type="species:ncbi:10090">transgenic mice</span>
###xml 959 974 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1051 1056 <span type="species:ncbi:10090">mouse</span>
Recently, we used microdissected DNA from 1q21 to select region-specific transcripts from an HCC case with 1q21 amplification, and one candidate oncogene, named chromodomain helicase DNA binding protein 1-like gene (CHD1L, also called ALC1), was isolated [9]. CHD1L belongs to the SNF2-like family, containing a conserved SNF2_N domain, a helicase superfamily domain (HELICc) and a Macro domain. In our previous study, we found that CHD1L has strong oncogenic ability including increasing cell proliferation, colony formation in soft agar, and tumor formation in nude mice, and inhibiting tumor cell apoptosis [9]. To further investigate the in vivo oncogenic role of CHD1L, CHD1L ubiquitous-expression transgenic mouse model was generated and characterized in this study. Spontaneous tumors were found in 10 transgenic mice over 22 months of period. In addition, ethanol intoxication was found to promote the susceptibility of liver tumor formation in CHD1L-transgenic mice. The molecular mechanism of CHD1L in HCC development was also studied using mouse embryo fibroblasts (MEF).
###end p 10
###begin title 11
Results
###end title 11
###begin title 12
###xml 20 35 <span type="species:ncbi:10090">transgenic mice</span>
Generation of CHD1L transgenic mice
###end title 12
###begin p 13
###xml 28 35 28 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 48 53 48 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 55 60 55 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 121 126 121 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 159 166 159 166 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 1A</bold>
###xml 159 166 159 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006727-g001"><bold>Fig. 1A</bold></xref>
###xml 384 391 384 391 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 1B</bold>
###xml 384 391 384 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006727-g001"><bold>Fig. 1B</bold></xref>
###xml 490 499 490 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006727-g001">Figure 1B</xref>
###xml 643 650 643 650 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
###xml 643 650 643 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0006727-t001"><bold>Table 1</bold></xref>
###xml 650 651 650 651 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">,</bold>
###xml 651 658 651 658 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 1D</bold>
###xml 651 658 651 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006727-g001"><bold>Fig. 1D</bold></xref>
###xml 658 659 658 659 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 675 679 675 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BamH</italic>
###xml 750 755 750 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 811 816 811 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 881 888 881 888 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 1D</bold>
###xml 881 888 881 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006727-g001"><bold>Fig. 1D</bold></xref>
###xml 94 99 <span type="species:ncbi:10090">mouse</span>
###xml 462 467 <span type="species:ncbi:9606">human</span>
To further characterize the in vivo function of CHD1L, CHD1L ubiquitous-expression transgenic mouse model was generated. CHD1L was cloned into plasmid pCAGGS (Fig. 1A) and linearized constructs were injected into 773 F1 eggs and 40 pups were obtained. Among them, 4 independent founders including 3 males (lines 3, 26 and 38) and 1 female (line 21), were identified by PCR screening (Fig. 1B). Expression of CHD1L was confirmed by Northern blot analysis using a human specific CHD1L probe (Figure 1B). Two founders (lines 21 and 38) were capable of transmitting the transgene to their offspring and thus chosen for further functional studies (Table 1,Fig. 1D). Two different BamHI fragments (6 kb in line 21 and 8 kb in line 38) containing transgene CHD1L were detected by Southern blot analysis, implying that CHD1L was integrated into different genomic sites in lines 21 and 38 (Fig. 1D).
###end p 13
###begin title 14
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 31 36 <span type="species:ncbi:10090">mouse</span>
Generation of CHD1L-transgenic mouse model.
###end title 14
###begin p 15
###xml 26 31 26 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 69 74 69 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 102 107 102 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 464 467 464 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bam</italic>
###xml 508 513 508 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 566 569 566 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bam</italic>
###xml 20 25 <span type="species:ncbi:9606">human</span>
###xml 86 91 <span type="species:ncbi:10090">mouse</span>
###xml 119 124 <span type="species:ncbi:10090">mouse</span>
###xml 285 290 <span type="species:ncbi:10090">mouse</span>
(A) Construction of human CHD1L gene in pCAGGS for the generation of CHD1L-transgenic mouse. (B) Four CHD1L-transgenic mouse (#3, 21, 26, and 38) founders were identified by PCR screening. Genomic DNA from cloned CHD1L was used as positive controls. (C) CHD1L expression in transgenic mouse (#38) was confirmed by Northern blot analysis. (D) Two founders (lines 21 and 38) were able to transmit the transgene to their offspring (P1). Genomic DNA was digested with BamHI and DNA fragment containing transgene CHD1L was detected by Southern blot analysis. The size of BamHI-DNA fragment was 6 kb in line 21 and 8 kb in line 38, implying their integrated sites in host genomic DNA are different .
###end p 15
###begin title 16
###xml 17 22 17 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
Summarization of CHD1L-transgenic founders and their offspring for tumorigenicity studies.
###end title 16
###begin p 17
###xml 30 35 30 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
Total number of offspring and CHD1L-transgenic offspring (in blanket) were used for ethanol intoxication study.
###end p 17
###begin p 18
###xml 30 35 30 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
Total number of offspring and CHD1L-transgenic offspring (in blanket) were used for spontaneous tumor formation study.
###end p 18
###begin title 19
###xml 26 41 <span type="species:ncbi:10090">transgenic mice</span>
Characterization of CHD1L-transgenic mice
###end title 19
###begin p 20
###xml 73 78 73 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 376 383 376 383 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 2A</bold>
###xml 376 383 376 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006727-g002"><bold>Fig. 2A</bold></xref>
###xml 673 680 673 680 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 2B</bold>
###xml 673 680 673 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006727-g002"><bold>Fig. 2B</bold></xref>
###xml 788 795 788 795 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 2C</bold>
###xml 788 795 788 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006727-g002"><bold>Fig. 2C</bold></xref>
###xml 922 929 922 929 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 2C</bold>
###xml 922 929 922 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006727-g002"><bold>Fig. 2C</bold></xref>
###xml 932 937 932 937 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 57 62 <span type="species:ncbi:9606">human</span>
###xml 67 72 <span type="species:ncbi:10090">mouse</span>
###xml 124 129 <span type="species:ncbi:10090">mouse</span>
###xml 164 169 <span type="species:ncbi:10090">mouse</span>
###xml 330 335 <span type="species:ncbi:10090">mouse</span>
###xml 453 457 <span type="species:ncbi:10090">mice</span>
###xml 485 490 <span type="species:ncbi:9606">human</span>
###xml 631 646 <span type="species:ncbi:10090">transgenic mice</span>
###xml 667 671 <span type="species:ncbi:10090">mice</span>
###xml 723 738 <span type="species:ncbi:10090">transgenic mice</span>
###xml 938 953 <span type="species:ncbi:10090">transgenic mice</span>
DNA sequence comparison showed that the homology between human and mouse CHD1L is about 81.2%. The endogenous expression of mouse CHD1L was studied by RT-PCR using mouse-specific primers and the result showed that high level expression of CHD1L was detected in brain, heart, lung, kidney and stomach. Low expression of endogenous mouse CHD1L was observed in liver and spleen (Fig. 2A). The expression of transgene CHD1L in CHD1L-transgenic and wildtype mice was tested by RT-CPR using human-specific primers. The results showed that expression of CHD1L was detected in all tested tissues (brain, heart, liver, lung, and kidney) in transgenic mice but not in wildtype mice (Fig. 2B). The expression of CHD1L in the liver of transgenic mice was firstly detected at embryonic stage 13.5dpc (Fig. 2C). The expression of CHD1L increased at 16dpc till 1 week after birth, and then decreased slightly at 3 to 20 weeks postnatal (Fig. 2C). CHD1L-transgenic mice were indistinguishable from wild-type siblings by size and weight.
###end p 20
###begin title 21
###xml 26 41 <span type="species:ncbi:10090">transgenic mice</span>
Characterization of CHD1L-transgenic mice.
###end title 21
###begin p 22
###xml 15 20 <span type="species:ncbi:10090">mouse</span>
###xml 65 70 <span type="species:ncbi:10090">mouse</span>
###xml 265 269 <span type="species:ncbi:10090">mice</span>
###xml 298 303 <span type="species:ncbi:9606">human</span>
###xml 330 334 <span type="species:ncbi:10090">mice</span>
(A) Endogenous mouse CHD1L expression was tested by RT-PCR using mouse-specific primers. Weak expression of CHD1L was detected in liver and spleen. GAPDH was used as internal control. (B) Expression of transgene CHD1L in multiple tissues of transgenic and wildtype mice was studied by RT-PCR using human-specific primers in adult mice. GAPDH was used as internal control. (C) Expression of CHD1L in liver at different ages was tested by RT-PCR. 18S rRNA was used as loading control.
###end p 22
###begin title 23
###xml 60 75 <span type="species:ncbi:10090">transgenic mice</span>
Ethanol intoxication promotes liver tumor susceptibility in transgenic mice
###end title 23
###begin p 24
###xml 100 105 100 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 137 142 137 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 382 387 382 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 485 492 485 492 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 3A</bold>
###xml 485 492 485 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006727-g003"><bold>Fig. 3A</bold></xref>
###xml 551 558 551 558 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 3B</bold>
###xml 551 558 551 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006727-g003"><bold>Fig. 3B</bold></xref>
###xml 613 618 613 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 636 643 636 643 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 3C</bold>
###xml 636 643 636 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006727-g003"><bold>Fig. 3C</bold></xref>
###xml 715 722 715 722 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 3D</bold>
###xml 715 722 715 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006727-g003"><bold>Fig. 3D</bold></xref>
###xml 106 121 <span type="species:ncbi:10090">transgenic mice</span>
###xml 143 158 <span type="species:ncbi:10090">transgenic mice</span>
###xml 162 166 <span type="species:ncbi:10090">mice</span>
###xml 388 403 <span type="species:ncbi:10090">transgenic mice</span>
###xml 479 483 <span type="species:ncbi:10090">mice</span>
###xml 619 634 <span type="species:ncbi:10090">transgenic mice</span>
###xml 709 713 <span type="species:ncbi:10090">mice</span>
To investigate whether ethanol intoxication is able to promote the susceptibility of liver tumor in CHD1L-transgenic mice, wild type and CHD1L-transgenic mice (6 mice for each group) were exposed to ethanol intoxication for a period of 12 weeks. Liver pathology and the presence of a glossy appearance on the surface of the liver between the two groups of animals were compared. In CHD1L-transgenic mice, a visible liver solid tumor and an adipoma were observed in two different mice (Fig. 3A). Histology study confirmed that the liver tumor was HCC (Fig. 3B). Severe dysplasia lesion was observed in three other CHD1L-transgenic mice (Fig. 3C). No visible tumor and dysplasia lesion was detected in wildtype mice (Fig. 3D).
###end p 24
###begin title 25
###xml 67 72 67 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 73 88 <span type="species:ncbi:10090">transgenic mice</span>
Ethanol intoxication promotes the susceptibility of liver tumor in CHD1L-transgenic mice.
###end title 25
###begin p 26
###xml 67 72 67 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 245 250 245 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 566 571 566 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 689 694 689 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 73 88 <span type="species:ncbi:10090">transgenic mice</span>
###xml 263 268 <span type="species:ncbi:10090">mouse</span>
###xml 374 379 <span type="species:ncbi:10090">mouse</span>
###xml 572 587 <span type="species:ncbi:10090">transgenic mice</span>
###xml 707 712 <span type="species:ncbi:10090">mouse</span>
###xml 753 758 <span type="species:ncbi:10090">mouse</span>
(A) A visible liver tumor (left) and adipoma (right) were found in CHD1L-transgenic mice following the ethanol exposure. (B) Histological study confirms the liver tumor is HCC. (C) Representative example of severe dysplasia lesion observed in a CHD1L- transgenic mouse following the ethanol exposure. (D) Representative example of normal liver tissue observed in a wildtype mouse following the ethanol exposure. (E) PCNA staining results showed that the frequency of cell proliferation (PCNA positive staining cells, indicated by arrows) was significantly higher in CHD1L-transgenic mice than that in wildtype littermates. (F) Representative example of AFP positive staining detected in a CHD1L- transgenic mouse and AFP negative staining in a wildtype mouse, respectively, after the ethanol exposure.
###end p 26
###begin p 27
###xml 76 81 76 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 292 293 292 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 300 307 300 307 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 3E</bold>
###xml 300 307 300 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006727-g003"><bold>Fig. 3E</bold></xref>
###xml 369 374 369 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 430 437 430 437 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 3F</bold>
###xml 430 437 430 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006727-g003"><bold>Fig. 3F</bold></xref>
###xml 106 110 <span type="species:ncbi:10090">mice</span>
###xml 228 243 <span type="species:ncbi:10090">transgenic mice</span>
###xml 375 390 <span type="species:ncbi:10090">transgenic mice</span>
###xml 577 582 <span type="species:ncbi:10090">mouse</span>
Following ethanol intoxication, the frequency of cell proliferation between CHD1L-transgenic and wildtype mice was compared by PCNA staining. The result revealed that the cell proliferation frequency was significantly higher in transgenic mice (5.5%) than that of wildtype littermates (1.6%, p<0.05, Fig. 3E). In addition, the expression of AFP can only be detected in CHD1L-transgenic mice but not in their wildtype littermates (Fig. 3F). Taken together, these observations suggest that overexpression of CHD1L in hepatocytes promotes the susceptibility of tumor formation in mouse.
###end p 27
###begin title 28
###xml 37 52 <span type="species:ncbi:10090">transgenic mice</span>
Spontaneous tumor formation in CHD1L-transgenic mice
###end title 28
###begin p 29
###xml 67 72 67 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 373 380 373 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0006727-t002">Table 2</xref>
###xml 475 481 475 481 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 4</bold>
###xml 475 481 475 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006727-g004"><bold>Fig. 4</bold></xref>
###xml 560 567 560 567 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 4B</bold>
###xml 560 567 560 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006727-g004"><bold>Fig. 4B</bold></xref>
###xml 634 639 634 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 675 695 675 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006727-g004">Figure 4 (4C and 4D)</xref>
###xml 869 876 869 876 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 5A</bold>
###xml 869 876 869 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006727-g005"><bold>Fig. 5A</bold></xref>
###xml 1053 1068 1053 1068 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figs. 5A and 5B</bold>
###xml 1053 1068 1053 1068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006727-g005"><bold>Figs. 5A and 5B</bold></xref>
###xml 1089 1096 1089 1096 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 5C</bold>
###xml 1089 1096 1089 1096 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006727-g005"><bold>Fig. 5C</bold></xref>
###xml 1154 1161 1154 1161 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 5D</bold>
###xml 1154 1161 1154 1161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006727-g005"><bold>Fig. 5D</bold></xref>
###xml 1161 1163 1161 1163 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">).</bold>
###xml 73 88 <span type="species:ncbi:10090">transgenic mice</span>
###xml 105 109 <span type="species:ncbi:10090">mice</span>
###xml 196 211 <span type="species:ncbi:10090">transgenic mice</span>
###xml 414 418 <span type="species:ncbi:10090">mice</span>
###xml 487 492 <span type="species:ncbi:10090">mouse</span>
###xml 640 655 <span type="species:ncbi:10090">transgenic mice</span>
###xml 700 705 <span type="species:ncbi:10090">mouse</span>
###xml 930 945 <span type="species:ncbi:10090">transgenic mice</span>
Only first-generation offspring from founder lines #21 and #38 (41 CHD1L-transgenic mice and 39 wildtype mice) were used as study cohort. Spontaneous tumor formation was observed in 10/41 (24.4%) transgenic mice, but not in their 39 wild-type littermates over a monitoring period of 22 months. The places of tumor formed and their pathological diagnosis were summarized in Table 2. Liver tumors were observed in 4 mice and histological study revealed that they were all HCC (Fig. 4). In mouse 2, two liver tumors in similar size were found in different lobes (Fig. 4B, indicated by arrows). Two other spontaneous HCC tumors formed in CHD1L-transgenic mice were also shown in Figure 4 (4C and 4D). In mouse 5, two spontaneous tumors were found, one in the neck and the other in the uterus. Histological study revealed that they were salivary acinic cell adenocarcinoma (Fig. 5A) and uterine adenofibroma, respectively. In 10 CHD1L-transgenic mice suffered with tumor, different tumor types were found including HCC, salivary acinic cell adenocarcinoma, (Figs. 5A and 5B), rhabdomyosarcoma (Fig. 5C), gall bladder adenocarcinoma, and colon adenocarcinoma (Fig. 5D).
###end p 29
###begin title 30
###xml 41 46 41 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 47 62 <span type="species:ncbi:10090">transgenic mice</span>
Detection of spontaneous liver tumors in CHD1L-transgenic mice.
###end title 30
###begin p 31
###xml 59 64 59 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 187 192 187 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 350 355 350 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 76 81 <span type="species:ncbi:10090">mouse</span>
###xml 204 209 <span type="species:ncbi:10090">mouse</span>
###xml 356 371 <span type="species:ncbi:10090">transgenic mice</span>
(A) Representative example of a visible liver tumor in one CHD1L-transgenic mouse (left), which was diagnosed as HCC by histological study (right). (B) Two liver tumors were found in one CHD1L-transgenic mouse (left, indicated by arrows) and histological study confirmed they are HCCs. (C and D) Representative examples of other two HCCs observed in CHD1L-transgenic mice.
###end p 31
###begin title 32
###xml 57 72 <span type="species:ncbi:10090">transgenic mice</span>
Detection of spontaneous tumors in other organs in CHD1L-transgenic mice.
###end title 32
###begin p 33
###xml 58 63 58 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 64 79 <span type="species:ncbi:10090">transgenic mice</span>
Besides HCC, several other different tumors were found in CHD1L-transgenic mice including salivary acinic cell adenocarcinoma (A and B), rhabdomyosarcoma (C), and colon adenocarcinoma (D).
###end p 33
###begin title 34
###xml 48 53 48 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 54 69 <span type="species:ncbi:10090">transgenic mice</span>
Summarization of spontaneous tumor formation in CHD1L-transgenic mice.
###end title 34
###begin p 35
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse number was listed as M1 to M10. Offspring from founder #21 or #38 was shown in blanket.
###end p 35
###begin title 36
Overexpression of CHD1L promotes cell cycle in transgenic MEF
###end title 36
###begin p 37
###xml 47 52 47 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 177 182 177 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 270 277 270 277 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 6A</bold>
###xml 270 277 270 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006727-g006"><bold>Fig. 6A</bold></xref>
###xml 403 410 403 410 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 6B</bold>
###xml 403 410 403 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006727-g006"><bold>Fig. 6B</bold></xref>
###xml 564 568 564 568 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">kip1</sup>
###xml 613 618 613 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 801 805 801 805 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">kip1</sup>
###xml 837 842 837 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 888 895 888 895 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 6C</bold>
###xml 888 895 888 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006727-g006"><bold>Fig. 6C</bold></xref>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 53 68 <span type="species:ncbi:10090">transgenic mice</span>
Mouse embryonic fibroblasts (MEF) derived from CHD1L-transgenic mice and their wildtype littermates were established using embryos at 13.5dpc. Pool of two wildtype MEFs and two CHD1L-transgenic MEFs were tested and their CHD1L expression level was determined by RT-PCR (Fig. 6A). DNA content analysis with MEF cells by flow cytometry found that CHD1L could facilitate DNA synthesis and G1/S transition (Fig. 6B). To address the possible pathway involved, expressions of several cell cycle-related genes, including Rb, Cyclin A, Cyclin D1, Cyclin E, CDK2, CDK4, p27kip1, and p53 were compared between wildtype and CHD1L-transgenic MEFs. The results showed that expressions of Cyclin A, Cyclin D1, CDK2, and CDK4 were notably up-regulated and a slight increase in CyclinE expression level, while Rb, p27kip1 and p53 were down-regulated in CHD1L-transgenic MEFs compared with wildtype MEFs (Fig. 6C).
###end p 37
###begin title 38
###xml 55 60 55 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
Overexpression of CHD1L promotes cell proliferation in CHD1L-transgenic MEF.
###end title 38
###begin p 39
###xml 47 52 47 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 171 176 171 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 349 353 349 353 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 377 382 377 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 88 92 <span type="species:ncbi:10090">mice</span>
(A) Detection of CHD1L expression in MEFs from CHD1L-transgenic (Tg) and wild type (Wt) mice by RT-PCR. GAPDH was used as internal control. (B) Examples of DNA content in CHD1L-transgenic and wild type MEFs detected by flow cytometry. (C) Western blot analyses indicated that Cyclin D1, Cyclin A and CDK2, 4 were up-regulated, whiles p53, Rb and p27Kip1 were down-regulated in CHD1L-transgenic MEFs compared with their wild type MEFs (pool of two MEFs). beta-actin was used as loading control.
###end p 39
###begin title 40
Discussion
###end title 40
###begin p 41
###xml 453 457 453 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006727-Wang1">[10]</xref>
###xml 493 498 493 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 656 661 656 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 673 678 <span type="species:ncbi:10090">mouse</span>
Amplification of 1q21 is one of the most frequently detected genetic changes in HCC. Activation of oncogene plays critical role in cancer development and one common mechanism of oncogene activation is overexpression caused by DNA amplification. Our previous study showed that amplification of 1q21 is an early event in HCC development, implying that the putative oncogene within this region may play important role in the initiation of HCC pathogenesis [10]. Recently, one candidate oncogene, CHD1L, was isolated from 1q21 and our previous study has demonstrated its oncogenic ability. In this report, we described the generation and characterization of a CHD1L-transgenic mouse model.
###end p 41
###begin p 42
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 101 106 101 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 218 223 218 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 430 435 430 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 560 565 560 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 644 649 644 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 862 866 862 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006727-He1">[11]</xref>
###xml 883 887 883 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006727-Schulten1">[12]</xref>
###xml 910 914 910 914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006727-KiuruKuhlefelt1">[13]</xref>
###xml 940 945 940 945 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 17 22 <span type="species:ncbi:10090">mouse</span>
###xml 436 451 <span type="species:ncbi:10090">transgenic mice</span>
###xml 650 665 <span type="species:ncbi:10090">transgenic mice</span>
CHD1L transgenic mouse model established in this study provides a very useful tool for investigating CHD1L function and role in cancer development. Two founders (#21 and #38) were capable of transmissing the transgene CHD1L to their offspring and Southern blot analysis found that their integrating sites are different. Therefore, these two lines were selected for further study. Spontaneous tumor formation was found only in old CHD1L-transgenic mice (over 20 months old), implying that the initiation and progression of HCC carcinogenesis caused by abnormal CHD1L expression is a long process. Several different types of tumors were found in CHD1L-transgenic mice including HCC, salivary, colon, uterine, and gall bladder adenocarcinoma, and rhabdomyosarcoma. Amplification of 1q has been also frequently detected in other solid tumors, including colon cancer [11], uterine cancer [12], and rhabdomyosarcoma [13]. These data suggest that CHD1L may play an important role in cancer development in many solid tumors.
###end p 42
###begin p 43
###xml 314 318 314 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006727-Pani1">[14]</xref>
###xml 376 381 376 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 382 397 <span type="species:ncbi:10090">transgenic mice</span>
To shorten the latency of tumor onset, alcohol intoxication was employed to induce hepatocyte pathological lesions. Alcohol is one the major risk factor for hepatocellular carcinoma, especially in western countries. Alcohol intoxication is a simple but efficient way to induce liver lesions in cancer-prone marine [14]. Interestingly, after 12 weeks alcohol treatment, 5/6 of CHD1L-transgenic mice had liver lesions, including HCC, adipoma, and severe dysplasia. However, no obvious precancerous lesion was detected in wildtype controls. In addition, overexpression of CHD1L could increase hepatocyte proliferation and induce AFP expression in transgenic liver post alcohol treatment. These results suggest that overexpression of CHD1L in liver increases the tumor susceptibility.
###end p 43
###begin p 44
###xml 134 139 134 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 209 214 209 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 393 396 393 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006727-Ma1">[9]</xref>
###xml 444 449 444 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 570 575 570 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 630 635 630 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 715 719 715 719 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 732 736 732 736 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 897 901 897 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006727-Sherr1">[15]</xref>
###xml 903 907 903 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006727-Vogelstein1">[16]</xref>
###xml 938 942 938 942 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 1194 1198 1194 1198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006727-Harbour1">[17]</xref>
###xml 1329 1333 1329 1333 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 1428 1437 1428 1437 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Waf1/Cip1</sup>
###xml 1590 1595 1590 1595 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 1810 1815 1810 1815 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
Promotion of cell proliferation is a major molecular mechanism of oncogene in cancer development. In this study, we demonstrated that CHD1L could facilitate DNA synthesis and promoted G1/S phase transition in CHD1L-transgenic MEFs. This result is consistent with our previous finding, in which overexpression of CHD1L in QGY-7703 (HCC cell line) cells could also promote G1/S phase transition [9]. To further explore the molecular mechanism of CHD1L in cell cycle promotion, expressions of several G1/S phase transition checkpoint related proteins were compared between CHD1L-transgenic and wildtype MEFs. The results showed that CHD1L could up-regulate Cyclin A, Cyclin D1, CDK2 and CDK4, and down-regulate Rb, p27Kip1 and p53. p27Kip1 serves as a key mediator in G1/S transition through Cdk inhibition and regulating the activity of cyclin D-Cdk4/6 complex which are essential for S phase entry [15], [16]. The reduced expression of p27Kip1 facilitates the activation of cyclin D-Cdk4/6 complex, resulting in the cyclin D-Cdk4/6-medicated Rb phosphorylation and destruction of Rb-E2F binding. The releasing E2F activates the transcription of genes necessary for S phase entry and progression [17]. Overexpression of CHD1L might serve as mitogenic signal to induce expression of cyclin D-Cdk4/6 and inhibit the expression of p27Kip1. In addition, the p53 protein is a transcription factor that upregulates the expression of p21Waf1/Cip1, which in turn functions as a Cdk2 inhibitor to control S phase entry via the inactivation of cyclinE-Cdk2 complex. The notable upregulation of Cdk2 in CHD1L-transgenic MEFs suggested that the dysregulation of the p53-cyclinE-Cdk2 pathway might be also involved in CHD1L-induced G1/S transition. Taken together, the observations in the present study strongly support that CHD1L is a novel oncogene responsible for the 1q21 amplification event in HCC and plays an important role in the development of HCC via promoting cell cycle.
###end p 44
###begin title 45
Materials and Methods
###end title 45
###begin title 46
###xml 20 35 <span type="species:ncbi:10090">transgenic mice</span>
Generation of CHD1L-transgenic mice
###end title 46
###begin p 47
###xml 20 25 20 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 52 56 52 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EcoR</italic>
###xml 58 62 58 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EcoR</italic>
###xml 116 121 116 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 420 427 417 424 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 1A</bold>
###xml 420 427 417 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006727-g001"><bold>Fig. 1A</bold></xref>
###xml 440 445 437 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 664 669 655 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 699 704 690 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 761 765 752 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006727-Hogan1">[18]</xref>
###xml 26 41 <span type="species:ncbi:10090">transgenic mice</span>
###xml 110 115 <span type="species:ncbi:9606">human</span>
###xml 202 207 <span type="species:ncbi:9606">human</span>
###xml 316 321 <span type="species:ncbi:9606">human</span>
###xml 322 325 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 352 359 <span type="species:ncbi:9031">chicken</span>
###xml 434 439 <span type="species:ncbi:9606">human</span>
###xml 483 489 <span type="species:ncbi:9986">rabbit</span>
###xml 587 594 <span type="species:ncbi:9031">chicken</span>
###xml 705 720 <span type="species:ncbi:10090">transgenic mice</span>
For construction of CHD1L-transgenic mice, a 2.8-kb EcoRI-EcoRI fragment containing the open reading frame of human CHD1L gene (Gene Bank accession no. AF537213), which was amplified by PCR from normal human liver cell line LO-2 complementary DNA, was cloned into plasmid pCAGGS. Expression of CHD1L was driven by a human CMV-IE enhancer linked to the chicken beta-actin promoter, followed by its first exom and intron (Fig. 1A). The human CHD1L has its own stop codon followed by a rabbit beta-globin poly(A) sequence. The mRNA transcript of the transgene consists of the first exon of chicken beta-actin, which is transcribed but not translated, followed by the CHD1L transgene. The generation of CHD1L-transgenic mice was performed using the standard method [18]. Briefly, the linearized constructs were injected into one-cell-stage F1 eggs (DBAxC57BL/6), which were transplanted into pseudo-pregnant females (average 12 eggs per oviduct).
###end p 47
###begin p 48
###xml 165 188 165 188 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AGCGCCTGGCTTCTTACTGC</named-content>
###xml 199 225 199 225 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCTTATCCAGCAGGTGAAGCTTC</named-content>
###xml 232 237 232 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 343 348 343 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 414 421 414 421 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
###xml 414 421 414 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0006727-t001"><bold>Table 1</bold></xref>
###xml 528 551 528 551 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGAGGAGGAAGCCTAGAACC</named-content>
###xml 562 585 562 585 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CGCTGCTTCCTGTCTTTTCT</named-content>
###xml 132 137 <span type="species:ncbi:9606">human</span>
###xml 349 364 <span type="species:ncbi:10090">transgenic mice</span>
###xml 381 385 <span type="species:ncbi:10090">mice</span>
###xml 424 429 <span type="species:ncbi:10090">Mouse</span>
###xml 495 500 <span type="species:ncbi:10090">mouse</span>
All resulting pups were screened for the presence of the transgene by PCR using genomic DNA obtained from tail snips with a pair of human-specific primers (Forward: 5'-AGCGCCTGGCTTCTTACTGC; Reverse: 5'-GCTTATCCAGCAGGTGAAGCTTC). The CHD1L-transgenic founders were crossed with wildtype F1 (DBA/C57bl6) and their first-generation offsprings (47 CHD1L-transgenic mice and 45 wildtype mice) were used as study cohort (Table 1). Mouse endogenous CHD1L expression was tested by RT-PCR using a pair of mouse-specific primers (Forward: 5'-GGAGGAGGAAGCCTAGAACC; Reverse: 5'-CGCTGCTTCCTGTCTTTTCT). Animal experimentation was done according to the institutional guidelines (Association for Assessment and Accreditation of Laboratory Animal Care International) for animal care. All the animal experiments were approved by the Committee on the Use of Live Animals in Teaching and Research (CULATR), The University of Hong Kong.
###end p 48
###begin title 49
Southern and Northern blot analyses
###end title 49
###begin p 50
###xml 71 75 67 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BamH</italic>
###xml 187 189 177 179 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 215 220 205 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 363 365 349 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 381 386 367 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 209 214 <span type="species:ncbi:9606">human</span>
###xml 375 380 <span type="species:ncbi:9606">human</span>
For Southern blot analysis, 10 microg of genomic DNA was digested with BamHI, fractionated on 1% agarose gel, transferred to a nylon membrane, and hybridized overnight at 42degreesC with 32P-labeled probe for human CHD1L gene. For Northern blot analysis, 20 microg of total cellular RNA was size fractionated, transferred to a nylon membrane, and hybridized with 32P-labeled human CHD1L gene.
###end p 50
###begin title 51
Ethanol intoxication
###end title 51
###begin p 52
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 110 120 110 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ad libitum</italic>
###xml 6 21 <span type="species:ncbi:10090">transgenic mice</span>
###xml 57 61 <span type="species:ncbi:10090">mice</span>
CHD1L-transgenic mice and their wild type littermates (6 mice for each group) at age of 20-weeks old were fed ad libitum a mixture containing increasing concentrations of ethanol (10% for 2 days; 15% for 3 days and thereafter 20%) in 20% sucrose during the entire treatment period (12 weeks). This mixture was the only source of drinking fluid for the animal for the entire duration of the experiment. Animals were then kept without ethanol for 4 weeks before sacrificed.
###end p 52
###begin title 53
Histological and pathological study
###end title 53
###begin p 54
Animals with visible tumors were sacrificed when signs of distress appeared. Tumors were immediately removed and fixed in 10% formalin for 24 hr. After dehydration, the tumor tissues were paraffin embedded. Serial sections (5 microm in thickness) were prepared, stained with Mayer's hematoxylin-eosin (H&E), and examined under microscope by two independent pathologists. Immunohistochemistry (IHC) was performed using standard streptavidin-biotin-peroxidase complex method with anti PCNA and AFP (Santa Cruz Biotechnology, Santa Cruz, CA) antibodies.
###end p 54
###begin title 55
###xml 14 19 <span type="species:ncbi:10090">mouse</span>
Generation of mouse embryo fibroblast (MEF)
###end title 55
###begin p 56
###xml 16 21 <span type="species:ncbi:10090">mouse</span>
Pregnant female mouse at 13.5 dpc was sacrificed and embryos were collected. The embryos were minced thoroughly with sterile scissors and then digested in 0.2% typsin (Sigma, St. Louis, MO) at 37degreesC for 10 min. The cell suspension was cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% FBS at 37degreesC.
###end p 56
###begin title 57
Detection of DNA content by flow cytometry
###end title 57
###begin p 58
###xml 15 20 15 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
DNA content in CHD1L-transgenic MEF and wildtype MEF was compared by flow cytometry. Cells were fixed in 70% ethanol for at least 1 hr and stained with staining solution (100 microg/ml RNase, 0.02% Triton X-100, 10 microg/ml propidium iodide) for 1 hr. Samples were analyzed using FACSCalibur flow cytometer and CellQuest software (BD Biosciences, San Jose, CA).
###end p 58
###begin title 59
Western blotting analysis
###end title 59
###begin p 60
###xml 330 334 326 330 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">kip1</sup>
For Western blotting, 20 microg of protein extract was separated by SDS-polyacrylamide gel electrophoresis and transferred to a PVDF Hybond-P membrane (Amersham Pharmacia Biotechnology, Piscataway, NJ). Western blot analyses were performed by a standard method with antibodies to Rb, Cyclin D1, Cyclin A, Cyclin E, CDK2, CDK4, p27kip1, p53 and beta-Actin (Cell Signaling Technology, Beverley, MA).
###end p 60
###begin title 61
Statistical analysis
###end title 61
###begin p 62
###xml 41 47 41 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L-</italic>
###xml 164 169 164 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHD1L</italic>
###xml 235 236 235 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
The difference of PCNA positive cells in CHD1L-transgenic liver and wildtype counterparts was compared with Student's T-test. The difference of DNA content between CHD1L-transgenic and wildtype MEFs was compared with Student's T-test. P values of <0.05 were considered to be significant.
###end p 62
###begin title 63
References
###end title 63
###begin article-title 64
Hepatocellular carcinoma.
###end article-title 64
###begin article-title 65
###xml 22 30 <span type="species:ncbi:9606">patients</span>
Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States.
###end article-title 65
###begin article-title 66
Epidemiology, risk factors, and natural history of hepatocellular carcinoma.
###end article-title 66
###begin article-title 67
Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization.
###end article-title 67
###begin article-title 68
Genetic aberrations detected by comparative genomic hybridization in hepatocellular carcinomas: their relationship to clinicopathological features.
###end article-title 68
###begin article-title 69
Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: relationship to disease stage, tumor size, and cirrhosis.
###end article-title 69
###begin article-title 70
Recurrent chromosome alterations in hepatocellular carcinoma detected by comparative genomic hybridization.
###end article-title 70
###begin article-title 71
###xml 66 71 <span type="species:ncbi:9606">human</span>
The association of chromosome 8p deletion and tumor metastasis in human hepatocellular carcinoma.
###end article-title 71
###begin article-title 72
Isolation and characterization of a novel oncogene, amplified in liver cancer 1, within a commonly amplified region at 1q21 in hepatocellular carcinoma.
###end article-title 72
###begin article-title 73
Prognostic significance of c-myc and AIB1 amplification in hepatocellular carcinoma. A broad survey using high-throughput tissue microarray.
###end article-title 73
###begin article-title 74
###xml 87 95 <span type="species:ncbi:9606">patients</span>
Recurrent genetic alterations in 26 colorectal carcinomas and 21 adenomas from Chinese patients.
###end article-title 74
###begin article-title 75
Overrepresentation of 8q in carcinosarcomas and endometrial adenocarcinomas.
###end article-title 75
###begin article-title 76
DNA copy number changes in alveolar soft part sarcoma: a comparative genomic hybridization study.
###end article-title 76
###begin article-title 77
###xml 104 108 <span type="species:ncbi:10090">mice</span>
Abrogation of hepatocyte apoptosis and early appearance of liver dysplasia in ethanol-fed p53-deficient mice.
###end article-title 77
###begin article-title 78
CDK inhibitors: positive and negative regulators of G1-phase progression.
###end article-title 78
###begin article-title 79
Surfing the p53 network.
###end article-title 79
###begin article-title 80
Cdk phosphorylation triggers sequential intranmolecular interactions that progressively block Rb functions as cells move through G1.
###end article-title 80
###begin article-title 81
###xml 63 78 <span type="species:ncbi:10090">transgenic mice</span>
Molecular biology. Enhancers, chromosome position effects, and transgenic mice.
###end article-title 81
###begin p 82
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 82
###begin p 83
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by Research Grant Council Grant (HKU 7393/04M), Research Fund for the Control of Infectious Diseases RFCID (02040162), Hong Kong Research Grant Council Central Allocation (HKU 1/06C), Sun Yat-Sen University "Hundred Talents Program" (85000-3171311), and the Major State Basic Research Program of China (2006CB910104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 83

